Mineo Kudo

Sapporo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Multicenter observational study on functional bowel disorders diagnosed using Rome III diagnostic criteria in Japan.

Multicenter observational study on functional bowel disorders diagnosed using Rome III diagnostic criteria in Japan.

Journal: Journal of gastroenterology

Published: May 14, 2017

Daclatasvir and asunaprevir in hemodialysis patients with hepatitis C virus infection: a nationwide retrospective study in Japan.

Daclatasvir and asunaprevir in hemodialysis patients with hepatitis C virus infection: a nationwide retrospective study in Japan.

Journal: Journal of gastroenterology

Published: February 27, 2017

Safety and efficacy of daclatasvir and asunaprevir in hepatitis C virus-infected patients with renal impairment.

Safety and efficacy of daclatasvir and asunaprevir in hepatitis C virus-infected patients with renal impairment.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: August 08, 2016

Efficacy and safety of daclatasvir and asunaprevir combination therapy in chronic hemodialysis patients with chronic hepatitis C.

Efficacy and safety of daclatasvir and asunaprevir combination therapy in chronic hemodialysis patients with chronic hepatitis C.

Journal: Journal of gastroenterology

Published: November 09, 2015

Open-label, randomized, comparative, phase III study on effects of reducing steroid use in combination with Palonosetron.

Open-label, randomized, comparative, phase III study on effects of reducing steroid use in combination with Palonosetron.

Journal: Cancer science

Published: February 05, 2015

Serum granulysin levels as a predictor of serious telaprevir-induced dermatological reactions.

Serum granulysin levels as a predictor of serious telaprevir-induced dermatological reactions.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: June 09, 2014

Factors affecting response to proton pump inhibitor therapy in patients with gastroesophageal reflux disease: a multicenter prospective observational study.

Factors affecting response to proton pump inhibitor therapy in patients with gastroesophageal reflux disease: a multicenter prospective observational study.

Journal: Journal of gastroenterology

Published: April 28, 2014

Multi-center randomized controlled study to establish the standard third-line regimen for Helicobacter pylori eradication in Japan.

Multi-center randomized controlled study to establish the standard third-line regimen for Helicobacter pylori eradication in Japan.

Journal: Journal of gastroenterology

Published: September 04, 2012

Optimal dose period for indisetron tablets for preventing chemotherapy-induced nausea and vomiting with modified FOLFOX6: a randomized pilot study.

Optimal dose period for indisetron tablets for preventing chemotherapy-induced nausea and vomiting with modified FOLFOX6: a randomized pilot study.

Journal: Chemotherapy

Published: July 13, 2012

Phase II study of combined chemotherapy with irinotecan and S-1 (IRIS) plus bevacizumab in patients with inoperable recurrent or advanced colorectal cancer.

Phase II study of combined chemotherapy with irinotecan and S-1 (IRIS) plus bevacizumab in patients with inoperable recurrent or advanced colorectal cancer.

Journal: Acta oncologica (Stockholm, Sweden)

Published: May 05, 2012

Showing 1-10 of 10

Last Updated: 09/26/2026